Emerging Infectious Disease Diagnostics Global Market Report 2025

Global Emerging Infectious Disease Diagnostics Market Report 2025

Emerging Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral, Bacterial, Fungal, Other Infections), By Disease Type (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types), By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies), By Application (Laboratory Testing, Point-of-Care Testing), By End-User (Hospitals And Clinics, Diagnostics Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Emerging Infectious Disease Diagnostics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Emerging Infectious Disease Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Emerging Infectious Disease Diagnostics Global Market Report 2025

Proud Members Of

Emerging Infectious Disease Diagnostics Market Definition

Emerging infectious disease diagnostics refers to the advanced methods and tools used to detect new or re-emerging infectious diseases caused by pathogens such as viruses, bacteria, or parasites. These diagnostics leverage cutting-edge technologies such as molecular testing, genomics, and rapid assays to identify infections quickly and accurately, improving public health responses. They are crucial in monitoring and controlling outbreaks, as well as in developing targeted treatments and vaccines.

The main infection types of emerging infectious disease diagnostics are viral, bacterial, fungal, and others. Viral infections are diseases caused by viruses, which are tiny pathogens that replicate inside the host's cells. The disease includes respiratory infections, gastrointestinal infections, and sexually transmitted infections (STIs), and the technologies are polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (inaat), next-generation sequencing (NGS), immunodiagnostics, and others. The different applications are laboratory testing and point-of-care testing and are used by various end-users such as hospitals and clinics, diagnostics laboratories, and others.

Emerging Infectious Disease Diagnostics Market Segmentation

The emerging infectious disease diagnostics market covered in this report is segmented –

1) By Infection Type: Viral, Bacterial, Fungal, Other Infections

2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types

3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies

4) By Application: Laboratory Testing, Point-of-Care Testing

5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users

Subsegments:

1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections

2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria

3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections

4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections

Emerging Infectious Disease Diagnostics Market Size and growth rate 2025 to 2029: Graph

Emerging Infectious Disease Diagnostics Market Size 2025 And Growth Rate

The emerging infectious disease diagnostics market size has grown strongly in recent years. It will grow from $22.13 billion in 2024 to $24.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for point-of-care diagnostics, increasing prevalence of infectious diseases, increasing global population density, rising incidence of infectious diseases, and increasing healthcare expenditure.

Emerging Infectious Disease Diagnostics Market Growth Forecast

The emerging infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $35.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of zoonotic diseases, significant growth in regulatory changes and support, development of universal vaccines, increasing focus on one health approach, and rising government support and funding. Major trends in the forecast period include technological advancements, next-generation sequencing (NGS), isothermal amplification techniques, telemedicine and remote diagnostics, and environmental pathogen monitoring.

Book your 30 minutes free consultation with our research experts

Emerging Infectious Disease Diagnostics Market Driver: Impact Of Rising Zoonotic Diseases On Emerging Infectious Disease Diagnostics Market

The rising incidence of zoonotic diseases is expected to propel the growth of the emerging infectious disease diagnostics market going forward. Zoonotic diseases refer to infections that can be transmitted from animals to humans, caused by bacteria, viruses, parasites, or fungi. The rising incidence of zoonotic diseases is primarily due to increased human-wildlife interactions, habitat destruction, and global travel, which facilitate pathogen transmission across species. Emerging infectious disease diagnostics help manage zoonotic diseases by enabling early detection and accurate identification of pathogens, allowing for prompt intervention, effective treatment, and better containment of disease outbreaks, thereby reducing transmission from animals to humans. For instance, in February 2024, according to the 2022 Zoonotic Disease Report published by State of West Virginia, a US-based government administration, in the MMWR Year 2022, the number of reported Lyme disease cases rose to 2,449, up from 1,788 cases in the 2021. Therefore, the rising incidence of zoonotic diseases is driving the emerging infectious disease diagnostics market.

Global Emerging Infectious Disease Diagnostics Market Major Players

Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

Global Emerging Infectious Disease Diagnostics Market Trend: Infectious Disease Diagnostics With High-Throughput Molecular Platform

Major companies operating in the emerging infectious disease diagnostics market are focusing on technological advancements such as molecular diagnostic platforms to gain a competitive edge. Molecular diagnostic platforms use nucleic acid amplification techniques to detect pathogens with high sensitivity and specificity, enabling accurate diagnosis and early detection. For instance, in May 2022, Becton Dickinson and Company, a US-based medical equipment manufacturing company, launched the BD COR MX/PX System, a fully automated, high-throughput diagnostic platform. The system improves laboratory efficiency by automating the entire molecular workflow, from sample processing to results. Its initial assay, the BD CTGCTV2, detects three prevalent non-viral sexually transmitted infections (STIs). The BD COR MX/PX System can process up to 1,700 specimens with onboard reagent and sample capacity, providing over seven hours of continuous operation and delivering up to 1,000 results in 24 hours, greatly reducing manual handling by lab technicians.

Emerging Infectious Disease Diagnostics Market Merger And Acquisition: Bio-Rad Laboratories Inc. Acquires Curiosity Diagnostics To Expand Molecular Diagnostics Capabilities

In August 2022, Bio-Rad Laboratories Inc., a US-based life science research and clinical diagnostics company, acquired Curiosity Diagnostics for $170 million. This acquisition is significant for Bio-rad as it enhances their offerings by incorporating curiosity diagnostics' PCR|ONE platform, a rapid diagnostics system designed specifically for molecular diagnostics. Curiosity Diagnostics is a Poland-based biotechnology research company that specializes in molecular diagnostic systems for managing infectious diseases.

Regional Outlook For The Global Emerging Infectious Disease Diagnostics Market

North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the emerging infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Emerging Infectious Disease Diagnostics Market?

The emerging infectious disease diagnostics market consists of revenues earned by entities by providing services such as laboratory testing, diagnostic tool development, clinical interpretation of test results, surveillance and reporting, and the provision of telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The emerging infectious disease diagnostic market also includes sales of rapid test kits, polymerase chain reaction (PCR) machines, molecular diagnostic assays, sequencing platforms, point-of-care diagnostic devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Emerging Infectious Disease Diagnostics Industry?

The emerging infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides emerging infectious disease diagnostics market statistics, including emerging infectious disease diagnostics industry global market size, regional shares, competitors with a emerging infectious disease diagnostics market share, detailed emerging infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the emerging infectious disease diagnostics industry. This emerging infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Emerging Infectious Disease Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	24.34 billion
Revenue Forecast In 2034	$35.21 billion
Growth Rate	CAGR of 9.7% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The emerging infectious disease diagnostics market covered in this report is segmented – 1) By Infection Type: Viral, Bacterial, Fungal, Other Infections 2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types 3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies 4) By Application: Laboratory Testing, Point-of-Care Testing 5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users Subsegments: 1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections 2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria 3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections 4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Emerging Infectious Disease Diagnostics Market Characteristics

3. Emerging Infectious Disease Diagnostics Market Trends And Strategies

4. Emerging Infectious Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emerging Infectious Disease Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Emerging Infectious Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Emerging Infectious Disease Diagnostics Market Growth Rate Analysis

5.4. Global Emerging Infectious Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Emerging Infectious Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Emerging Infectious Disease Diagnostics Total Addressable Market (TAM)

6. Emerging Infectious Disease Diagnostics Market Segmentation

6.1. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral

Bacterial

Fungal

Other Infections

6.2. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Respiratory Infections

Gastrointestinal Infections

Sexually Transmitted Infections (STIs)

Other Disease Types

6.3. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Next-Generation Sequencing (NGS)

Immunodiagnostics

Other Technologies

6.4. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Testing

Point-of-Care Testing

6.5. Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostics Laboratories

Other End-Users

6.6. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Respiratory Viruses

Hepatitis Viruses

HIV and Retroviruses

Arboviruses

Herpesviruses

Gastrointestinal Viruses

Emerging Viral Infections

6.7. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tuberculosis (TB)

Methicillin-Resistant Staphylococcus Aureus (MRSA)

Escherichia Coli (E. coli) Infections

Streptococcus and Pneumococcus Infections

Clostridium Infections

Neisseria

Emerging Drug-Resistant Bacteria

6.8. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Candidiasis

Aspergillosis

Cryptococcosis

Histoplasmosis

Coccidioidomycosis

Pneumocystis Pneumonia (PCP)

Emerging Fungal Infections

6.9. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Parasitic Infections

Protozoan Infections

Prion Diseases

Helminthic Infections

Non-Pathogenic or Environmental Infections

7. Emerging Infectious Disease Diagnostics Market Regional And Country Analysis

7.1. Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emerging Infectious Disease Diagnostics Market

8.1. Asia-Pacific Emerging Infectious Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emerging Infectious Disease Diagnostics Market

9.1. China Emerging Infectious Disease Diagnostics Market Overview

9.2. China Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emerging Infectious Disease Diagnostics Market

10.1. India Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emerging Infectious Disease Diagnostics Market

11.1. Japan Emerging Infectious Disease Diagnostics Market Overview

11.2. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emerging Infectious Disease Diagnostics Market

12.1. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emerging Infectious Disease Diagnostics Market

13.1. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emerging Infectious Disease Diagnostics Market

14.1. South Korea Emerging Infectious Disease Diagnostics Market Overview

14.2. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emerging Infectious Disease Diagnostics Market

15.1. Western Europe Emerging Infectious Disease Diagnostics Market Overview

15.2. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emerging Infectious Disease Diagnostics Market

16.1. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emerging Infectious Disease Diagnostics Market

17.1. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emerging Infectious Disease Diagnostics Market

18.1. France Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emerging Infectious Disease Diagnostics Market

19.1. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emerging Infectious Disease Diagnostics Market

20.1. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emerging Infectious Disease Diagnostics Market

21.1. Eastern Europe Emerging Infectious Disease Diagnostics Market Overview

21.2. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emerging Infectious Disease Diagnostics Market

22.1. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emerging Infectious Disease Diagnostics Market

23.1. North America Emerging Infectious Disease Diagnostics Market Overview

23.2. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emerging Infectious Disease Diagnostics Market

24.1. USA Emerging Infectious Disease Diagnostics Market Overview

24.2. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emerging Infectious Disease Diagnostics Market

25.1. Canada Emerging Infectious Disease Diagnostics Market Overview

25.2. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emerging Infectious Disease Diagnostics Market

26.1. South America Emerging Infectious Disease Diagnostics Market Overview

26.2. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emerging Infectious Disease Diagnostics Market

27.1. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emerging Infectious Disease Diagnostics Market

28.1. Middle East Emerging Infectious Disease Diagnostics Market Overview

28.2. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emerging Infectious Disease Diagnostics Market

29.1. Africa Emerging Infectious Disease Diagnostics Market Overview

29.2. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emerging Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles

30.1. Emerging Infectious Disease Diagnostics Market Competitive Landscape

30.2. Emerging Infectious Disease Diagnostics Market Company Profiles

30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Emerging Infectious Disease Diagnostics Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company

31.2. Laboratory Corporation of America Holdings

31.3. Quest Diagnostics Incorporated

31.4. Agilent Technologies Inc.

31.5. Hologic Inc.

31.6. Illumina Inc.

31.7. bioMérieux SA

31.8. QuidelOrtho Corporation

31.9. Bio-Rad Laboratories, Inc.

31.10. Qiagen N.V.

31.11. DiaSorin S.p.A.

31.12. Randox Laboratories Ltd.

31.13. Meridian Bioscience Inc.

31.14. Sekisui Diagnostics LLC

31.15. Copan Diagnostics

32. Global Emerging Infectious Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emerging Infectious Disease Diagnostics Market

34. Recent Developments In The Emerging Infectious Disease Diagnostics Market

35. Emerging Infectious Disease Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Emerging Infectious Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Emerging Infectious Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Emerging Infectious Disease Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Roche Diagnostics Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Abbott Laboratories Financial Performance

Table 83: Danaher Corporation Financial Performance

Table 84: Siemens Healthineers Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Roche Diagnostics Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Abbott Laboratories Financial Performance

Figure 83: Danaher Corporation Financial Performance

Figure 84: Siemens Healthineers Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Breast Cancer Diagnostics Global Market Report 2025 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By Cancer Type (BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types), By Diagnostic Type (Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies), By End Users (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cervical Cancer Diagnostics Global Market Report 2025 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By Age Group (Below 21, Age between 21 to 29, Age between 30 to 65, Above 65), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transplant Diagnostics Global Market Report 2025 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancreas), By Technology (Non Molecular Assay, Molecular Assay), By End User (Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Transfusion Diagnostics Global Market Report 2025 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Diagnostics Devices And Equipment Global Market Report 2025 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Emerging Infectious Disease Diagnostics market?

How will the Emerging Infectious Disease Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Emerging Infectious Disease Diagnostics industry going forward?

The Emerging Infectious Disease Diagnostics market major growth driver - Impact Of Rising Zoonotic Diseases On Emerging Infectious Disease Diagnostics Market. For further insights on the Emerging Infectious Disease Diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Emerging Infectious Disease Diagnostics market?

The Emerging Infectious Disease Diagnostics market size has grown strongly in recent years. The emerging infectious disease diagnostics market size has grown strongly in recent years. It will grow from $22.13 billion in 2024 to $24.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for point-of-care diagnostics, increasing prevalence of infectious diseases, increasing global population density, rising incidence of infectious diseases, and increasing healthcare expenditure. The emerging infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $35.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of zoonotic diseases, significant growth in regulatory changes and support, development of universal vaccines, increasing focus on one health approach, and rising government support and funding. Major trends in the forecast period include technological advancements, next-generation sequencing (NGS), isothermal amplification techniques, telemedicine and remote diagnostics, and environmental pathogen monitoring. For further insights on the Emerging Infectious Disease Diagnostics market, request a sample here

How is the Emerging Infectious Disease Diagnostics market segmented?

The emerging infectious disease diagnostics market covered in this report is segmented –
1) By Infection Type: Viral, Bacterial, Fungal, Other Infections
2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies
4) By Application: Laboratory Testing, Point-of-Care Testing
5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users Subsegments:
1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections
4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections For further insights on the Emerging Infectious Disease Diagnostics market, request a sample here

Which region has the largest share of the Emerging Infectious Disease Diagnostics market? What are the other regions covered in the report?

Who are the major players in the Emerging Infectious Disease Diagnostics market?

What are the key trends in the Emerging Infectious Disease Diagnostics market?

Major trends in the Emerging Infectious Disease Diagnostics market include Infectious Disease Diagnostics With High-Throughput Molecular Platform. For further insights on the Emerging Infectious Disease Diagnostics market, request a sample here.

What are the major opportunities in the Emerging Infectious Disease Diagnostics market? What are the strategies for the Emerging Infectious Disease Diagnostics market?

For detailed insights on the major opportunities and strategies in the Emerging Infectious Disease Diagnostics market, request a sample here.

How does the Emerging Infectious Disease Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Emerging Infectious Disease Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Emerging Infectious Disease Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Emerging Infectious Disease Diagnostics industry, request a sample here.

What are the key dynamics influencing the Emerging Infectious Disease Diagnostics market growth? SWOT analysis of the Emerging Infectious Disease Diagnostics market.

For detailed insights on the key dynamics influencing the Emerging Infectious Disease Diagnostics market growth and SWOT analysis of the Emerging Infectious Disease Diagnostics industry, request a sample here.